Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I

Journal of Nuclear Medicine

Volumn 38, Issue 11, 1997, Pages 1767-1769

  Perez Monte, Juan E ^a   Brown, Manuel L ^a   Clarke, Martha R ^a   Watson, Charles G ^a   Carty, Sally E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Carcinoid; Hyperparathyroidism; Multiple endocrine neoplasia I; Parathyroid adenoma; Sestimibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CARCINOID; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GASTRINOMA; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; HYPOPHYSIS ADENOMA; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ISLET; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARCINOID TUMOR; FEMALE; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID GLANDS; PITUITARY NEOPLASMS; PROLACTINOMA; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYMUS NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030691972     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gagel RF. Multiple endocrine neoplasia. In: Wilson J, Foster D. Williams textbook of endocrinology, 8th ed. Philadelphia, PA: Saunders 1992;1537-1553.
2. Skogseid B, Eriksson B, Lundquist G, et al. Multiple endocrine neoplasia Type I: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991;73:281-287.
3. Van Heerden JA, Kent RB III, Sizemore GW, Grant CS, ReMine WH. Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Arch Surg 1983;118:533-536.
4. Leshin M. Multiple endocrine neoplasia. In: Wilson J, Foster D, eds. Williams textbook of endocrinology, 7th ed. Philadelphia, PA: Saunders 1989;1274-1290.
5. Benson L, Ljunghall S, Akerstrom G, Oberg K. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type I. Am J Med 1987;82:731-737.
6. Underdahl LO, Woolner LB, Black BM. Multiple endocrine adenomas, report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. J Clin Endocrinol Metab 1953;13:20-47.
7. Holman BL, Jones AG, Lister-James J, et al. A new Tc-99m-labeled myocardial imaging agent, hexakis (t-butylisonitrile)-technetium(I) [Tc-99mTBI], Initial experience in the human. J Nucl Med 1984;25:1350-1355.
8. Zeiger MA, Swartz SE, MacGillivray DC, Linnoila I, Shakir M. Thymic carcinoid in association with MEN syndromes. Am Surg 1992;58:430-434.
9. Asbun HJ, Calabria PP, Calmes S, Lang AG, Bloch JH. Thymic carcinoid. Am Surg 1991;57:442-445.
10. Duh Q-Y, Hybarger CP, Geist R, et al. Carcinoid associated with multiple endocrine neoplasia syndromes. Am J Surg 1987;54:142-148.
11. Wackers FJT, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1990;31:1646-1653.
12. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxy-isobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.
13. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 1991;21:173-181.
14. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, et al. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990;50:2198-2202.
15. Campeau RJ, Kronemer KA, Sutherland CM. Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor. Clin Nucl Med 1992;17:936-937.
16. Caner B, Kitapci M, Aras T, et al. Increased accumulation of hexakis (2methoxyisobutylisonitrile) technetium(I) in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991;32:1977-1978.
17. Strouse PJ, Wang DC. Incidental detection of bronchogenic carcinoma during Tc-99m sestamibi cardiac imaging. Clin Nucl Med 1993;18:448-449.
18. Kitapci MT, Tastekin G, Turgut M, et al. Preoperative localization of parathyroid carcinoma using Tc-99m MIBI. Clin Nucl Med 1993;18:217-218.
19. O'Driscoll CM, Baker F, Casey MJ, et al. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoisobutylnitrile scintigraphy: a case report. J Nucl Med 1991;32::2281-2283.
20. Chen LB. Mitochondrial membrane potentials in living cells. Ann Rev Cell Biol 1988;4:155-181.
21. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors. Preliminary results and comparison with Tl-201. Clin Nucl Med 1992;17:171-176.
22. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins REC. Tc-99m sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794.
23. O'Doherty MJ, Kettle AG, Wells T, et al. Parathyroid imaging with technetium 99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313-318.
24. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m sestamibi (double phase study). J Nucl Med 1992;33: 1801-1807.